Quality Care
Eversana senior vice president of health innovation, Alberta Spreafico, discusses the company's collaboration with the Digital Therapeutics Alliance to analyze frameworks and map reimbursement pathways in Europe for digital health adoption.
HIMSS24
Emmanuel Bilbault, cofounder and CEO of POSOS, says the company's AI-driven international drug database's use of medication codes enables it to cross-reference EHR data and tailor prescriptions to meet a patient's specific needs.
The companies will create a value-based care program to support cardiology patients and providers at health systems and CINs.
Kaiser Permanente Georgia VP & COO Heidi Veltman discusses how next-generation imaging can help create better outcomes by providing crisper scans and improving diagnostic visibility.
The company will use the funds to expand its workforce, including its sales team, in order to broaden its biopharma partnerships.
The funding comes a year after the company announced an expanded relationship with OpenAI to develop a chatbot for healthcare providers built on GPT-4.
Unlimited Heart Health & Wellness founder Jim Kaveney discusses the platform he is developing for atrial fibrillation patients and their caretakers and his goal of partnering with patient advocacy groups, nonprofits and healthcare systems in the future.
HIMSS24
Zsolt Kulcsar, Lee Health's systems medical director of virtual health, discusses his team's upcoming AI chatbot, which will contact patients with unusual RPM biometric readings to determine if alerting a nurse is necessary.
It has also received Australia's regulatory approval for its AI solution.
The company will use the investment to expand its reach across the U.S. and develop new technologies.